US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist
  • 48.360
  • +0.540+1.13%
Close Aug 23 16:00 ET
  • 48.360
  • 0.0000.00%
Post 19:18 ET
2.83BMarket Cap14.64P/E (TTM)

Apogee Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-101.10%-29.3M
-199.67%-31.64M
-355.11%-74.76M
-223.80%-29.75M
-19.88M
-14.57M
-10.56M
-16.43M
-9.19M
Net income from continuing operations
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
---20.84M
---18.89M
---12.53M
---39.79M
---14.01M
Depreciation and amortization
--36K
--29K
----
----
----
--0
--0
----
----
Other non cash items
--280K
--266K
-99.24%87K
----
----
----
----
--11.4M
--563K
Change In working capital
-51.84%1.54M
-289.19%-1.31M
-37.80%6.11M
19.36%2.52M
---313K
--3.2M
--694K
--9.82M
--2.11M
-Change in prepaid assets
36.82%-1.21M
-3,222.73%-1.46M
-1,587.88%-2.79M
473.94%617K
---1.44M
---1.92M
---44K
---165K
---165K
-Change in payables and accrued expense
-40.14%3.07M
-44.17%412K
-7.14%9.27M
0.18%2.28M
--1.13M
--5.12M
--738K
--9.98M
--2.28M
-Change in other current assets
----
----
---107K
----
----
----
----
--0
----
-Change in other current liabilities
---244K
---263K
---270K
----
----
--0
--0
--0
----
Cash from discontinued investing activities
Operating cash flow
-101.10%-29.3M
-199.67%-31.64M
-355.11%-74.76M
-223.80%-29.75M
---19.88M
---14.57M
---10.56M
---16.43M
---9.19M
Investing cash flow
Cash flow from continuing investing activities
-148.71M
-51.74M
-273.91M
-39.69M
-234.22M
0
0
0
0
Net PPE purchase and sale
---51K
---351K
---167K
----
----
--0
--0
--0
----
Net investment purchase and sale
---148.66M
---51.39M
---273.74M
---39.53M
---234.22M
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
---148.71M
---51.74M
---273.91M
---39.69M
---234.22M
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
91.15%-150K
450.52M
87.38%315.39M
-100.13%-213K
317.3M
-1.69M
0
168.32M
158.5M
Net common stock issuance
---541K
--450.5M
--315.39M
97.83%-213K
--315.6M
--0
--0
--0
---9.82M
Net preferred stock issuance
----
----
--0
----
----
----
----
--168.32M
----
Proceeds from stock option exercised by employees
--391K
--24K
----
----
----
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
91.15%-150K
--450.52M
87.38%315.39M
-100.13%-213K
--317.3M
---1.69M
--0
--168.32M
--158.5M
Net cash flow
Beginning cash position
243.69%485.75M
-21.91%118.61M
--151.89M
7,188.77%188.27M
--125.07M
--141.33M
--151.89M
--0
--2.58M
Current changes in cash
-995.41%-178.16M
3,577.70%367.14M
-121.91%-33.28M
-146.65%-69.66M
--63.2M
---16.26M
---10.56M
--151.89M
--149.31M
End cash Position
145.94%307.59M
243.69%485.75M
-21.91%118.61M
-21.91%118.61M
--188.27M
--125.07M
--141.33M
--151.89M
--151.89M
Free cash flow
-101.45%-29.35M
-202.99%-31.99M
-356.13%-74.93M
-225.62%-29.92M
---19.88M
---14.57M
---10.56M
---16.43M
---9.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -101.10%-29.3M-199.67%-31.64M-355.11%-74.76M-223.80%-29.75M-19.88M-14.57M-10.56M-16.43M-9.19M
Net income from continuing operations -79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M---20.84M---18.89M---12.53M---39.79M---14.01M
Depreciation and amortization --36K--29K--------------0--0--------
Other non cash items --280K--266K-99.24%87K------------------11.4M--563K
Change In working capital -51.84%1.54M-289.19%-1.31M-37.80%6.11M19.36%2.52M---313K--3.2M--694K--9.82M--2.11M
-Change in prepaid assets 36.82%-1.21M-3,222.73%-1.46M-1,587.88%-2.79M473.94%617K---1.44M---1.92M---44K---165K---165K
-Change in payables and accrued expense -40.14%3.07M-44.17%412K-7.14%9.27M0.18%2.28M--1.13M--5.12M--738K--9.98M--2.28M
-Change in other current assets -----------107K------------------0----
-Change in other current liabilities ---244K---263K---270K----------0--0--0----
Cash from discontinued investing activities
Operating cash flow -101.10%-29.3M-199.67%-31.64M-355.11%-74.76M-223.80%-29.75M---19.88M---14.57M---10.56M---16.43M---9.19M
Investing cash flow
Cash flow from continuing investing activities -148.71M-51.74M-273.91M-39.69M-234.22M0000
Net PPE purchase and sale ---51K---351K---167K----------0--0--0----
Net investment purchase and sale ---148.66M---51.39M---273.74M---39.53M---234.22M--0--0--0--0
Cash from discontinued investing activities
Investing cash flow ---148.71M---51.74M---273.91M---39.69M---234.22M--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 91.15%-150K450.52M87.38%315.39M-100.13%-213K317.3M-1.69M0168.32M158.5M
Net common stock issuance ---541K--450.5M--315.39M97.83%-213K--315.6M--0--0--0---9.82M
Net preferred stock issuance ----------0------------------168.32M----
Proceeds from stock option exercised by employees --391K--24K--------------0--0--------
Cash from discontinued financing activities
Financing cash flow 91.15%-150K--450.52M87.38%315.39M-100.13%-213K--317.3M---1.69M--0--168.32M--158.5M
Net cash flow
Beginning cash position 243.69%485.75M-21.91%118.61M--151.89M7,188.77%188.27M--125.07M--141.33M--151.89M--0--2.58M
Current changes in cash -995.41%-178.16M3,577.70%367.14M-121.91%-33.28M-146.65%-69.66M--63.2M---16.26M---10.56M--151.89M--149.31M
End cash Position 145.94%307.59M243.69%485.75M-21.91%118.61M-21.91%118.61M--188.27M--125.07M--141.33M--151.89M--151.89M
Free cash flow -101.45%-29.35M-202.99%-31.99M-356.13%-74.93M-225.62%-29.92M---19.88M---14.57M---10.56M---16.43M---9.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg